ENTITY
Belite Bio

Belite Bio (BLTE US)

1
Analysis
Health CareUnited States
Belite Bio, Inc operates as a clinical stage biopharmaceutical drug development company. The Company focuses on developing novel therapeutics targeting untreatable age-related metabolic diseases, including macular degeneration, liver disease, and diabetes. Belite Bio serves customers in the United States.
more
Publication Icon
No publications yet
There aren’t any buy-side reports right now
Back to "All"
x